Last month, the CDC recommended one dose of Beyfortus for all infants younger than eight months born during or entering their first RSV season and also said one dose could be used in infants and ...

Reports of Guillain-Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination in adults ages 60 and up were higher than expected, but the vaccine's benefits still outweigh any ...